Prognostic significance of COVID-19 MSCT chest findings on short-term disease progression

The Egyptian Journal of Bronchology

Table 4 Comparison between group A (no. = 75), group B (no. = 125), group C (no. = 85), and group D (no. = 15) regarding lobar predominance

Lobar predominance	Group A		Group B		Group C		Group D		Test value*	p-value
Lobar predominance	No.	%	No.	%	No.	%	No.	%	Test value*	p-value
Lower	22	29.3%	18	14.4%	9	10.6%	5	33.3%	13.177	0.001
Upper	0	0.0%	0	0.0%	0	0.0%	0	0.0%
No	53	70.7%	107	85.6%	76	89.4%	10	66.7%

P-value > 0.05, nonsignificant (NS); P-value < 0.05, significant(S); P-value < 0.01, highly significant (HS). *Chi-square test, •one-way ANOVA test